ABVX Abivax S.A.
Healthcare$121.99-1.64%ClosedMarket Cap: $8.00B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$142.17
Target (Median)
$143.50
Target Range
$110.00 - $175.00
Upside from current price: 16.5%
Rating Distribution
4 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-24 | Barclays | maintain | Overweight | Overweight |
| 2026-02-25 | BTIG | maintain | Buy | Buy |
| 2026-01-09 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-01-08 | BTIG | maintain | Buy | Buy |
| 2025-12-16 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-10-10 | Guggenheim | maintain | Buy | Buy |
| 2025-10-07 | BTIG | maintain | Buy | Buy |
| 2025-09-25 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-09-12 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-07-29 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.85 | $124.8M | 4 |
| Sun Dec 31 | $1.17 | $604.3M | 3 |
| Mon Dec 31 | $6.49 | $1.21B | 1 |
| Tue Dec 31 | $8.05 | $1.62B | 1 |